Literature DB >> 23201251

VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

P K Multani1, R Hodge1, M A Estévez2, T Abel3, H Kung4, M Alter1, B Brookshire1, I Lucki5, A H Nall1, K Talbot1, G A Doyle1, F W Lohoff6.   

Abstract

Vesicular monoamine transporters (VMAT) are involved in presynaptic storage and release of neurotransmitters. While it was thought initially that only VMAT2 is brain expressed and VMAT1 is present only in the periphery, recent data have challenged the exclusive expression of VMAT2 in the brain. To further elucidate the role of VMAT1 brain expression and its potential role in neuropsychiatric disorders, we have investigated mice lacking VMAT1. Comparison of wildtype and knock-out (KO) mice using qPCR and immunohistochemistry documents the expression of VMAT1 in the brain. Deletion of VMAT1 leads to increased hippocampal apoptosis and reduced neurogenesis as assessed by caspase-3-labeling and 5-bromo-deoxy-uridine-labeling. Behavioral data show that mice lacking VMAT1 have neurocognitive deficits. VMAT2 expression is not altered in VMAT1 KO mice, suggesting a distinct role of VMAT1. Our data support VMAT1 brain expression and suggest that VMAT1 plays a key role in survival of hippocampal neurons and thus might contribute to neurocognitive deficits observed in neuropsychiatric disorders.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201251      PMCID: PMC4364608          DOI: 10.1016/j.neuroscience.2012.11.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  56 in total

1.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  A role for adult neurogenesis in spatial long-term memory.

Authors:  J S Snyder; N S Hong; R J McDonald; J M Wojtowicz
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia.

Authors:  Shih-Fen Chen; Chia-Hsiang Chen; Jen-Yeu Chen; Ying-Chieh Wang; I-Ching Lai; Ying-Jay Liou; Ding-Lieh Liao
Journal:  Schizophr Res       Date:  2007-01-16       Impact factor: 4.939

Review 4.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

5.  Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder.

Authors:  Falk W Lohoff; John P Dahl; Thomas N Ferraro; Steven E Arnold; Jürgen Gallinat; Thomas Sander; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

6.  Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.

Authors:  J K Zubieta; S F Taylor; P Huguelet; R A Koeppe; M R Kilbourn; K A Frey
Journal:  Biol Psychiatry       Date:  2001-01-15       Impact factor: 13.382

7.  Ephedrine decreases vesicular monoamine transporter-2 function.

Authors:  Jonathan D Ellis; Christopher L German; Elisabeth Birdsall; Jarom E Hanson; Marcus A Crosby; Shane D Rowley; Nicole A Sawada; Jeremiah N West; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2011-05       Impact factor: 2.562

8.  The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake.

Authors:  Irene Brunk; Christian Blex; Sivaramakrishna Rachakonda; Markus Höltje; Sandra Winter; Ingrid Pahner; Diego J Walther; Gudrun Ahnert-Hilger
Journal:  J Biol Chem       Date:  2006-08-22       Impact factor: 5.157

9.  Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

Authors:  Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

10.  Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.

Authors:  Hideko Yamamoto; Etsuko Kamegaya; Yoko Hagino; Kazuhide Imai; Akihiro Fujikawa; Kohei Tamura; Tomoyuki Enokiya; Toshifumi Yamamoto; Takao Takeshima; Hisashi Koga; George R Uhl; Kazutaka Ikeda; Ichiro Sora
Journal:  Neurochem Int       Date:  2007-06-29       Impact factor: 3.921

View more
  7 in total

1.  Protective effect of bone marrow mesenchymal stem cells on PC12 cells apoptosis mediated by TAG1.

Authors:  Yu-Zhen Zhang; Ji-Yu Lou; Hong-Ying Bai; Yun-Liang Wang; Jin-Feng Li; Hong-Lei Yin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Assessment of individual differences in the rat nucleus accumbens transcriptome following taste-heroin extended access.

Authors:  Caesar G Imperio; Ashley J McFalls; Elizabeth M Colechio; Dustin R Masser; Kent E Vrana; Patricia S Grigson; Willard M Freeman
Journal:  Brain Res Bull       Date:  2015-12-28       Impact factor: 4.077

3.  Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence.

Authors:  Xi Zhu; Nisha Dutta; Sarah G Helton; Melanie Schwandt; Jia Yan; Colin A Hodgkinson; Carlos R Cortes; Mike Kerich; Samuel Hall; Hui Sun; Monte Phillips; Reza Momenan; Falk W Lohoff
Journal:  Hum Brain Mapp       Date:  2015-09-14       Impact factor: 5.038

4.  Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.

Authors:  Hong-Fang Mei; Neha Poonit; Yi-Chun Zhang; Chu-Yuan Ye; Hui-Lin Cai; Chen-Yi Yu; Yong-Hai Zhou; Bei-Bei Wu; Jun Cai; Xiao-Hong Cai
Journal:  Mol Cell Biochem       Date:  2018-01-29       Impact factor: 3.396

Review 5.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

6.  Humanized substitutions of Vmat1 in mice alter amygdala-dependent behaviors associated with the evolution of anxiety.

Authors:  Daiki X Sato; Yukiko U Inoue; Nahoko Kuga; Satoko Hattori; Kensaku Nomoto; Yuki Morimoto; Giovanni Sala; Hideo Hagihara; Takefumi Kikusui; Takuya Sasaki; Yuji Ikegaya; Tsuyoshi Miyakawa; Takayoshi Inoue; Masakado Kawata
Journal:  iScience       Date:  2022-07-20

7.  Human-specific mutations in VMAT1 confer functional changes and multi-directional evolution in the regulation of monoamine circuits.

Authors:  Daiki X Sato; Yuu Ishii; Tomoaki Nagai; Kazumasa Ohashi; Masakado Kawata
Journal:  BMC Evol Biol       Date:  2019-12-02       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.